 |
|
Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma
Jae Kyeom Sim, Sang Mi Chung, Jong Hyun Choi, Jee Youn Oh, Seung Heon Lee, Je Hyeong Kim, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang, Bong Kyung Shin, Ju Han Lee, Sung Yong Lee
Korean J Intern Med. 2018;33(4):737-744. Published online 2018 Feb 20 DOI: https://doi.org/10.3904/kjim.2017.245
|
|
Citations to this article as recorded by
 Pulmonary Sarcomatoid Carcinoma: What Makes This Rare Lung Cancer So Challenging?
Badr Kharouaa, Amine Hayoune, Sara Gartini, Meriem Rhazari, Afaf Thouil, Hatim Kouismi
Cureus.2024;[Epub] CrossRef Pulmonary sarcomatoid carcinoma: A rare case report, diagnostic dilemma and review of literature
Xilin Liu, Lixin Guo, Xiangfu Ding, Zhichen Kang
Medicine.2024; 103(27): e38797. CrossRef An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma
Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizusihima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirok
Discover Oncology.2024;[Epub] CrossRef Targeted therapy for rare lung cancers: Status, challenges, and prospects
Chunsen Wang, Xiang Yuan, Jianxin Xue
Molecular Therapy.2023; 31(7): 1960. CrossRef PD-L1 Expression and Intra-Tumoral CD8+ T Lymphocytes in Esophageal Carcinosarcoma
Shusen Chen, Jiamin Zhu, Peng Wang, Dongdong Wan, Xiaojia Cui, Yunzhao Xu, Xingsong Zhang, Haibin Yin, Xudong Chen, Jing Cai, Xi Yang
Cancer Investigation.2022; 40(4): 337. CrossRef The treatment of advanced pulmonary sarcomatoid carcinoma
Yue Zheng, Yang Fu, Qin Zhong, Rong Deng, Yu Zhang
Future Oncology.2022; 18(6): 727. CrossRef Pulmonary Sarcomatoid Carcinoma
Fahad Gul, Harris Shaikh, Nicholas Mills, Joseph Pulito, Logan Ranzenberger, Avik Patel, Adeel Khalid, Mohamed Jaber
Applied Radiology.2022; : 48A. CrossRef Characteristics and Prognostic Analysis of 55 Patients With Pulmonary Sarcomatoid Carcinoma
Jiachun Sun, Zhiyi Jiang, Tanyou Shan, Ruina Yang, Dejiu Kong, Junshuai Rui, Xinyang Li, Guoqiang Kong, Baoping Chang
Frontiers in Oncology.2022;[Epub] CrossRef Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review
Yuchen Wan, Zhixue Wang, Ning Yang, Fenye Liu
Frontiers in Oncology.2022;[Epub] CrossRef The Prognosis of Pulmonary Sarcomatoid Carcinoma: Development and Validation of a Nomogram Based on SEER
Yuanyuan Xie, Zhiyong Lin, Haochun Shi, Xiang Sun, Lizhong Gu
Technology in Cancer Research & Treatment.2022;[Epub] CrossRef Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma
Chia-Ling Chang, Min-Shu Hsieh, Jin-Yuan Shih, Yi-Hsuan Lee, Wei-Yu Liao, Chia-Lin Hsu, Ching-Yao Yang, Kuan-Yu Chen, Jih-Hsiang Lee, Chao-Chi Ho, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Chong-Jen Yu
Therapeutic Advances in Medical Oncology.2022;[Epub] CrossRef Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma
Xuewen Liu, Fang Wang, Chunwei Xu, Xinru Chen, Xue Hou, Qian Li, Pansong Li, Zhi Xie, Yongdong Liu, Lianpeng Chang, Yanfang Guan, Xuchao Zhang, Ling Yang, Hui Wang, Xin Yi, Jianjun Zhang, Xuefeng Xia, Cesar Moran, Likun Chen
Oncogene.2021; 40(4): 821. CrossRef Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre Experience
Ferhat Ferhatoglu, Fahmin Amirov, Berker Ozkan, Murat Kara, Alper Toker, Naziye Ak, Esra Aydın, Nail Paksoy, Dilek Yilmazbayhan, Adnan Aydiner
Oncology Research and Treatment.2021; 44(11): 590. CrossRef Resected case of stage IV pleomorphic carcinoma of the lung with long-term survival
Haruki Choshi, Mototsugu Watanabe, Hiroyuki Ujike, Yumiko Sato, Toshiaki Morito, Ryujiro Sugimoto, Kazuhiko Kataoka
Surgical Case Reports.2020;[Epub] CrossRef First-line albumin-bound paclitaxel/carboplatin plus apatinib in advanced pulmonary sarcomatoid carcinoma
Feng-Wei Kong, Wei-Min Wang, Lei Liu, Wen-Bin Wu, Xiang Wang, Miao Zhang
Medicine.2020; 99(23): e20667. CrossRef Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report
Ping Chen, Min Yu, Ji-Liang Zhang, Wei-Yong Chen, Li Zhu, Yue Song, Cheng-Yi Jiang, Shuang Zhang
World Journal of Clinical Cases.2020; 8(13): 2876. CrossRef Pulmonary sarcomatoid carcinoma: progress, treatment and expectations
Xin Li, Di Wu, Hongyu Liu, Jun Chen
Therapeutic Advances in Medical Oncology.2020; 12: 175883592095020. CrossRef Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma
Xiaohong Liang, Yinan Cheng, Zijiang Yuan, Zhengping Yan, Quqing Li, Yuan Huang, Gaohua Feng
Oncology Letters.2020;[Epub] CrossRef 18F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma and correlation with clinical and genetic findings
Xiaodong Wu, Yan Huang, Yuan Li, Qiang Wang, Huoqiang Wang, Lei Jiang
Annals of Nuclear Medicine.2019; 33(9): 647. CrossRef A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review
Tomoo Kakimoto, Mamoru Sasaki, Tatsuya Yamamoto, Arifumi Iwamaru, Kentaro Ogata, Ko Lee, Shingo Nakayama, Naoto Minematsu
Case Reports in Oncological Medicine.2019; 2019: 1. CrossRef Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
Jiyun Lee, Hyun Ae Jung, Youjin Kim, Sangjoon Choi, Joungho Han, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Jong-Mu Sun
Lung Cancer.2018; 122: 160. CrossRef
|